Salmonella specifically localize to malignant tumors in vivo, a trait potentially exploitable as a delivery system for cancer therapeutics. To characterize mechanisms and genetic responses of Salmonella during interaction with living neoplastic cells, we custom 
Introduction
The evolving and highly heterogeneous landscape of tumor genetics and the tumor microenvironment pose a significant challenge for treating advanced solid tumors (1) .
Many characteristics of the tumor microenvironment, such as hypoxia, acidic pH, and a disorganized vascular architecture, limit delivery and efficacy of therapeutics and radiation treatments (2) . Additionally, tumors undergoing targeted molecular therapy often relapse due to the utilization of autonomous parallel-redundant signaling pathways (3) . Beyond the primary tumor, identifying disseminated disease that has metastasized to various organ sites is challenging, and systemically treating cancer often produces off-target toxicities. The ultimate anti-tumor therapy is one that overcomes these physiologic obstacles while simultaneously targeting tumors and avoiding normal tissue toxicity.
The remarkable ability of commensal and pathogenic bacterial strains to localize and preferentially grow within tumors has been well documented (4) . The immuneprivileged, hypoxic and nutrient-rich 'tumor soil' facilitates colonization by facultative anaerobic bacteria (5) . These observations have spurred research into the diagnostic and therapeutic potential of genetically engineered and attenuated therapeutic strains of bacteria such as Salmonella, Listeria and Clostridium (5) . Salmonella is one of the most studied of therapeutic bacteria, and upon systemic administration, is able to colonize xenograft tumors at rates 1,000 times greater than that of other organs, thereby abrogating tumor growth (6, 7) . A firm understanding of the genetic programs involved in normal pathogenesis, characterization of spatiotemporal kinetics and dynamics during intra-tumoral colonization in vivo, genetic tractability, as well as the 
Results

A high-throughput screen to identify tumor cell-induced gene activation events in Salmonella
To conduct a large-scale, unbiased screen for genes up-regulated by contact with malignant cells, we used a Tn5-based transposon as the backbone of a luxAB reporter construct. We chose to use the bacterial luciferase enzyme genes (luxAB) only, in contrast to the full bacterial luciferase operon (luxCDABE), because the size of the transposon containing the full operon prohibited efficient chromosomal integration, while using only the luxAB genes allowed for efficient genomic insertion of the transposon.
The transposon was designed to restrict reporter gene expression to only those chromosomal integration sites downstream of an active promoter. A kanamycin resistance cassette with a constitutive promoter was also included to select for integration into the chromosome (Figure 1a) . After construction, the purified transposon was electroporated into S. typhimurium strain SB300A1 (14) for random chromosomal integration, producing a 7,400 clone bacterial library. Initially, the entire Salmonella library was subjected to a primary screen in the context of three conditions: tissue culture media alone, B16F10 melanoma cells and HCT116 colon carcinoma cells, both of the latter in monolayer co-culture with the Salmonella reporter library. The tumor cells were grown in 96-well plate format overnight and then bacterial clones added to wells corresponding to each of the two co-culture conditions and media alone. After a two-hour incubation, bioluminescence imaging of plates enabled identification of clones specifically up-regulating genes in the context of exposure to melanoma and/or colon carcinoma cells (Figure 1a) . Results of the screen from co-culture with melanoma and colon carcinoma cells are shown in Figures 1b and   1c , respectively. In each case, data are shown as a rank-ordered S-plot of the log 2 of the normalized signal for each clone of the library, where normalized signal was the ratio of the signal in the condition of interest to the signal in media alone. The majority of data points clustered around zero, indicating that most mutants interrogated in the assay did not show tumor-specific gene regulation. However, quartile analysis with a boundary for hit selection corresponding to a high stringency targeted error rate (Į = 0.0027) identified five candidate mutants wherein the transposon reporter was specifically up-regulated during co-culture with malignant cells.
Verification and characterization of Salmonella gene activation events in the context of tumor cell co-culture
Following the primary screen, we utilized inverse touchdown PCR to map the specific location of each transposon in the Salmonella genome (15) . Table 1 involved in Salmonella-host interactions, nor involved in Salmonella colonization of neoplasia. Interestingly, the genomic insertion sites of the transposon in three of the clones inserted in a cluster in the chromosomal sequence. Mapped to three different, but closely linked genes (STM1787, STM1791 and STM1793, respectively), two are known hydrogenases, and all three genes are likely co-regulated and involved in the same Salmonella function. Sequencing showed that in one high stringency hit, the transposon had inserted into adiY, a Salmonella gene known to be involved in an acid tolerance response (16) . The transposon in the fifth clone was identified to have landed in yohJ, a putative membrane protein (17).
To validate cancer cell co-culture-specific gene activation events identified in the primary screen, we first repeated the co-culture assay in quadruplicate in at least three independent experiments for each clone. Figure 2a shows the data from one representative experiment for clones verified by this assay. Again, all five clones showed statistically significant enhancement of bioluminescence in the presence of tumor cells, with a trend toward greater gene up-regulation when co-cultured with B16F10 melanoma cells. Then, to further characterize tumor cell-induced response of Salmonella, we utilized the tumor cells in a dose-response assay (Figures 2b, c) .
Additionally, to verify that reporter activation seen in the Salmonella reporter-trap clones was not an effect of differing substrate permeability due to mutations in bacterial genes, bacteria were generated that contained the original chromosomal luxAB insertion as well as a plasmid constitutively expressing luxCDE, the biosynthetic genes for the longchain aldehydes that act as the optical substrates of the bacterial luciferase operon.
Therefore, for this assay, it was not necessary to add decanal to the media. Identical inoculations of bacteria showed greater up-regulation of the reporter when exposed to greater numbers of tumor cells in co-culture conditions, indicating that the stimuli from tumor cells instigated a graded response from the bacteria. Because expression of the lux operon genes fully complemented the use of exogenous decanal in the system, the data confirmed that the effect was not an artifact of exogenous decanal permeability in the primary screen.
Finally, to verify that the reporters in fact reflected mRNA transcriptional regulation in wild-type Salmonella during co-culture with tumor cells, we utilized semi-quantitative PCR. Following a three-hour co-culture of wild-type (SB3001A1) bacteria with B16F10 cells or in tissue culture media alone, isolated RNA was reverse transcribed to cDNA.
Semi-quantitative PCR of cDNA showed that co-culture with B16F10 melanoma cells enhanced the intensity of target gene transcripts, but not control ribosomal RNA transcripts (rrsH) (Figure 2d) . The effect was generalizable, as co-culture with HeLa tumor cells produced similar results (Figure 2d ).
Notably, of the genes identified in this screen, at least one, adiY, has previously been reported to be up-regulated in acidic pH conditions (16) . One characteristic of tumor microenvironments in vivo is an abnormally acidic pH (18). In fact, due to the Warburg effect, cancer cells are constitutively glycolytic, even in high oxygen conditions, releasing lactic acid and thereby creating a particularly acidic tumor microenvironment (19). For these reasons, the Salmonella transposon insertion mutants were further investigated for reporter signal activation in acidic conditions. normal body tissue (pH 7.5), suggesting that the stimulus Salmonella responded to in the context of neoplastic cells was microenvironment acidification.
To determine whether the activated genes were required for localization to tumors or required for colonization and growth within tumors in vivo, Salmonella strains null for genes identified in the screen were constructed. Selected genes were deleted using a lambda red recombinase insertional deletion strategy, which inserted a chloramphenicol resistance cassette into the targeted genes. The deletion mutants were created from a parental Salmonella strain (luxCDABE msbB-) containing a chromosomally-integrated and constitutively-expressed bacterial luciferase operon for imaging bacterial localtization in vivo in real time. The strain also contained a msbB gene deletion, which causes a less immunogenic LPS structure and minimizes septic shock effects when the strain is administered intravenously (20) . Based on the analysis that the identified STM1787, STM1791 and STM1793 genes were contained in a single operon, we targeted a large region of this operon for deletion in a single mutant strain, 1789
The gene adiY also appeared to be a part of a larger operon of co-regulated genes and was therefore targeted along with the adjacent genes adi and yjdE. The gene yohJ was targeted individually. In a B16F10 melanoma tumor xenograft model, all bacterial strains were injected via mouse tail vein and deletion mutants compared to the parental strain for localization to and persistence within the tumor using bioluminescence imaging (Supplementary Figure 1) . All mutant strains and the parent strain were capable of tumor localization and persistence, indicating that although the identified genes were activated by tumor cell co-culture in vitro, they were not essential for bacterial colonization of the tumor. The experiment was also performed in an HCT116 colon Additionally, in pilot competitive infection studies, there was no significant difference between the STM1789-1793 mutant and the parental Salmonella strain (luxCDABE msbB-) in tumor colonization (CFU/ml; data not shown).
Specificity and reversibility of the Salmonella STM1787 promoter in vivo
We next sought to demonstrate the specificity of the STM1787 promoter activation in the tumor microenvironment in vivo. We chose this promoter because it displayed the highest acidic pH induction in vitro (Figure 2a) . Here, we used the constitutively bioluminescent Salmonella strain Tn:27.8+pluxCDE or the conditionally bioluminescent strain Tn:1787+pluxCDE, each of which constitutively express plasmid-encoded luxCDE, but the latter strain will only bioluminesce upon activation of the chromosomally-encoded luxAB reporter. In a B16F10 melanoma tumor xenograft model, bacteria were injected via mouse tail vein or intratumorally and allowed two days to localize and adapt to tumors in vivo. Tumors were then excised, incubated in solutions of various pH values and imaged periodically for six hours. Initially, all tumors showed bioluminescent bacteria ex vivo. Over time, constitutive Tn:27.8 Salmonella showed a gradual increase in signal consistent with bacterial growth in the tumor explants. This behavior was also observed in the Tn:1787 Salmonella-infected tumor explants incubated in low pH media. By contrast, when the Tn:1787 Salmonella-infected tumor explants were maintained in basic media conditions throughout, the signal initially increased, but then plateaued around 4 hours and decreased in comparison to the constitutively bioluminescent Tn:27.8 strain (Figure 3b,c) . This finding suggested that bacterial gene expression was initially engaged by the low pH conditions of the in vivo tumor microenvironment, but after exposure to a higher pH environment ex vivo, the promoter driving the reporter was repressed and signal declined. Further, this ex vivo effect was reversible. When the medium on the Tn:1787 Salmonella-infected tumor explant was changed from pH 6.0 to pH 7.5, the bioluminescent signal decreased.
Conversely, when the media was changed from pH 7.5 to pH 6.0, the signal increased (Figure 3b, c) . These effects were not seen with the constitutive Tn:27.8 Salmonella- Because the identified promoters were highly activated in the tumor microenvironment ex vivo, utilization of these promoters provided a unique opportunity to design tumortargeting bacterial vectors subject to multiple levels of controlled specificity in vivo.
Thus, we sought to determine if the acidic pH of the tumor microenvironment could be exploited to specifically activate a target transgene during tumor localization. As proof of principle, we constructed Salmonella reporter strains expressing plasmids encoding the bacterial luciferase operon driven by either constitutive promoters or an inducible promoter to demonstrate tumor-mediated transgene activation in vivo. The plasmids pMAAC001 and pLux both encoded constitutively-expressed luciferase operons, while the pPROMOTERLux plasmid was engineered to contain the luciferase operon driven by the Salmonella candidate promoter (STM1787) comprising 500 base pairs upstream of the putative transcription start site of tumor-activated genes STM1787, STM1793 and STM1791 (which we will now refer to as the STM1787 promoter). Bacteria expressing (Figure 4a) . Concurrently, bacteria constitutively expressing pLux-or pMAAC001-luciferase showed <20-fold or no reporter activation, respectively, after exposure to the tumor microenvironment (Figures 4a and   4b ). These data directly demonstrated tumor-specific induction of a transgene from the Salmonella STM1787 promoter in an in vivo system. Therefore, the STM1787 promoter could be used as a platform to design tumor-targeting Salmonella strains capable of specifically delivering a therapeutic gene or toxin to the site of a tumor in vivo.
Selective anti-tumor therapy in vivo
We utilized the cancer cell-activated STM1787 promoter to regulate the expression of Shiga toxin 2 (Stx2), a toxic transgene of bacterial origin, in a wild type strain of S. In the P1787-Stx2-treated tumors, viable tumor cells were difficult to find, and in most sections, only a central necrotic zone surrounded by fibroinflammatory reaction was present. Note that mice treated with high-dose P1787-Stx2 eventually succumbed to the combined bacterial and Stx2 toxin load. However, mice receiving low-dose P1787-Stx2 were healthy for two weeks, at which point the experiment was concluded, but each still displayed a significant reduction in tumor size compared to P1787 alone (Figure 6b ).
Discussion
Salmonella typhimurium bacteria are typically classified as human gastrointestinal pathogens and a common cause of modern food-borne illness. However, another noted characteristic of Salmonella is the capacity to colonize tumor tissue. In fact, in the 1800's, physicians began to intentionally use bacteria as tumor therapeutics, but due to significant toxicity and lack of consistent, reliable results, these practices were abandoned. However, modern studies using attenuated strains and longitudinal imaging A number of studies utilize bacteria as treatment vectors per se or as drug delivery vehicles by exploiting their potentially low toxicity and high genetic tractability to maximize therapeutic efficacy (5) . In this regard, various attenuated Salmonella strains have been developed for use in tumor-targeting studies, including specific amino acid auxotrophs and LPS mutants (20, 32). However, the greatly reduced toxicity of Salmonella LPS mutants (msbB-) observed in swine models has not been observed in mouse models (33, 34) . In more than one instance, attenuated Salmonella have even been used in a clinical trial to treat cancer in humans (35, 36) . However, trials so far show relatively low rates of tumor colonization in human hosts, which may be due to excessive attenuation of the bacterial strains (5, 34) . Indeed, one study indicates that induction of TNFĮ by bacteria is necessary for optimal colonization of tumors (37) . Salmonella, we determined that the common stimulus for up-regulation of target gene expression was acidic pH. In another study aimed at identifying Salmonella promoters involved in tumor colonization in vivo, Salmonella genomic DNA was digested and ligated randomly upstream of a GFP reporter. In this study, the major stimulus identified in reporter activation was hypoxia, but no pH-regulated promoters were identified (38) . oxygen conditions, indicating that hypoxia may serve as a further stimulus for the pHinduced promoters identified in the present study (39) . However, in pilot studies with an incubation pouch system used for growing anaerobic bacteria, we did not observe any significant changes in transposon reporter activity under hypoxic conditions (KF, unpublished data). While these data do not necessarily rule out oxygen-independence, pH appeared to be the dominant signal inducing responses in the promoters identified by our bioluminescent transposon reporter-trap screen. It will also be of interest in future studies to determine if in addition to hypoxia, pH is another regulator of Salmonella promoters that contain the largely uncharacterized tusp motif.
In view of the usual pathophysiology of Salmonella, it is not surprising that Salmonella strains have gained the ability to precisely regulate genes in response to different pH environments. Salmonella encounter low pH conditions regularly during human infection, for example, during transit through the stomach, and later during intracellular trafficking through the phagosome (40, 41) . Interestingly, the acidic pH of the tumor environment in vivo has long been noted as an important microenvironmental condition when designing effective tumor treatments (18, 42). Additionally, the low pH environment of the tumor inhibits host defense. Cytotoxic immune cell activity and cytokine secretion has been shown to be impaired by a low extracellular pH (43) . In contrast, with a bacterial-driven tumor therapeutic, low pH may become an exploitable advantage, by adding another level of selectivity to bacterial gene activation. Indeed, the utility of a low pH-activated bacterial therapeutic will avoid toxicity to the liver and spleen which are the other major off-target organ sites of bacterial colonization, but 
which generally have a neutral pH (33). In this case, a bacterial-based system may succeed, while both conventional therapeutics and host defenses fail.
When using bacteria as a vector for drug delivery studies, tumor-specific colonization and subsequent expression is a major concern. The genes identified herein are highly expressed in an acidic tumor environment, but are not required for bacterial tumor targeting (Supplemental Figure 1) . Therefore, the promoters regulating these genes 10% FBS. In the plate containing media alone, each well contained 100 ȝl of DMEM with 10% FBS only. Plates were incubated overnight to allow tumor cell adhesion to the 96-well white plates. Independently, bacterial clones were grown overnight in LB broth with kanamycin in 96-well plates and subcultured the following day 1:10 into LB broth.
Five to six hours after subculturing, 30 ȝl of bacterial culture were added to three replicate plates, each corresponding to a separate culture condition. Bacteria were allowed to co-incubate with the malignant cells or media alone for 2 hours.
Subsequently, bacteria were imaged by adding 30 ȝl of decanal solution, waiting 10 minutes, and imaging with an IVIS 100 imaging system (Caliper; acquisition time, 60 sec; binning, 4; filter, < 510; f stop, 1; FOV, 23 cm) (46) . Because white plates were used to maximize signal intensity, images were aquired utilizing a <510 filter to reduce phosphorescence from the plates. Three control wells were included on every plate comprising: luxCDABE Salmonella (SB300A1FL6), which contain the full luciferase operon inserted into the chromosome; luxAB strain, which contains the luciferase enzyme genes only and therefore requires addition of exogenous substrate to image reporter activity in the assay; and a blank well, which contained media, but was not inoculated with bacteria, to serve as a control for background luminescence. Imaged plates were analyzed with Living Image (Caliper) and Igor (Wavemetric) analysis software packages as described (47) . Data were normalized by dividing the photon flux of experimental wells by media alone wells and presented as the log 2 of the normalized photon flux data. significant hits from the primary screens, we utilized a set of statistical requirements.
Identification of hits:
First, a threshold was set to identify active clones. Clones that did not produce photon signals greater than three standard deviations above the signal in the un-inoculated, media alone wells were not further analyzed. A quartile method of statistical analysis was then applied to the remaining clonal data (49) . For quartile analysis, plates of clones were grouped by assay date into sets for data analysis. For each set, we normalized data by calculating the log 2 of the fold-change of photon flux signal between the condition of interest (co-culture with B16F10 or HCT116 cells) and media alone.
From this data, we calculated the median (Q2), first (Q1), and third (Q3) quartile values.
The boundary for hit selection was calculated as Q3 + c(ICQ), where ICQ = Q3-Q1 and c = 1.7239, corresponding to a high stringency targeted error rate of Į = 0.0027 (49) . PCR products were fractionated on a 1% agarose gel.
Verification of primary screen hits:
Construction of deletion mutants: Mutant strains deficient for the identified target genes
were constructed in Salmonella strain luxCDABE msbB-(AM3), which contains a constitutively active, chromosomally-encoded bacterial luciferase operon as well as a mutation in msbB to create a less immunogenic LPS structure. Mutants were constructed using a lambda red recombinase strategy (50) . First, primers were 
analyzed with Living Image (Caliper) and Igor (Wavemetrics) analysis software packages as described (47) . Research. Agrawal, N., Bettegowda, C., Cheong, I., Geschwind, J. F., Drake, C. G., Hipkiss, E. L., et al. 
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